Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |